In2Bones

What In2Bones does

In2Bones is a US-based orthopedic medical device company founded in 2014 and headquartered in Memphis, Tennessee, focused on the design, manufacture, and commercialization of surgical products for the foot and ankle. The company built a comprehensive portfolio spanning fracture fixation plates and screws, soft tissue and ligament reconstruction implants, suture anchors, biologic scaffolds, and powered surgical instruments. Named product families include BioBrace® (a reinforced bioinductive implant combining PLLA and collagen for soft tissue reinforcement), QUANTUM® (a total ankle arthroplasty system with OrthoPlanify patient-specific instrumentation), NeoSpan® and Hercules® (fixation systems), CartiMax® (cartilage repair), MicroFree® (powered handpiece platform), TruShot® (microfracture awl), and CoLink® / TenoLok® / Y-Knot® (suture and tendon fixation technologies).

The company monetizes through unit sales of implants, disposable instrument components, and reusable instrument sets sold to hospitals, ambulatory surgery centers, and orthopedic surgeons. Its go-to-market is a direct-and-distributor hybrid model focused on foot and ankle specialists. In 2019, In2Bones was acquired by CONMED Corporation, and its products are now sold as part of CONMED's Foot and Ankle franchise with distribution reach across 100+ countries. The business model is fundamentally a specialty medical device hardware sale — one-time revenue per procedure, no recurring SaaS or consumable subscription layer, and no disclosed direct-to-patient or value-based-care contracting in the data.

Name

In2Bones

Legal name

CONMED Corporation

Website

https://i2b-usa.com

Company type

Public

Founded year

1970

Operating status

Operating

Headcount range

51–100 employees

Short description

In2Bones is a Memphis-based orthopedic medical device company specializing in foot and ankle surgical solutions, offering implants, biologics, fixation devices, and powered instruments to orthopedic surgeons and hospitals globally through its integration with CONMED.

Ownership category

akta.pro rank

Product category

Orthopedic Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Orthopedic implants
• Foot and ankle surgery
• Extremity fixation devices
• Surgical instrumentation
• Medical devices

Headquarters

HQ city

Memphis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device and Surgical Product Sales: CONMED generates revenue through the sale of medical devices, surgical implants, fixation devices, biologics, and surgical instrumentation to healthcare providers and surgical facilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

In2Bones designs, manufactures, and markets orthopedic implants and instrumentation for the upper and lower extremities. The company's product portfolio spans soft-tissue fixation, plating systems, compression screws, allograft implants, and surgical tools used by foot and ankle surgeons, orthopedic specialists, and surgical centers.

Product overview

CONMED is a medical device company offering a comprehensive portfolio of foot and ankle surgical solutions. The product ecosystem includes arthroplasty systems (QUANTUM® Total Ankle with OrthoPlanify™ PSI), fixation devices (NeoSpan® Compression Implant System, CoLink® plating systems), biologics (CartiMax® cartilage allograft), implants and suture anchors (BioBrace®, Hercules® anchors, TruShot® with Y-Knot®), surgical power tools (MicroFree®), and instrumentation. Products are organized by surgical application including Sports Medicine, Forefoot & Midfoot, Hindfoot & Ankle, and Biologics categories.

Differentiator

Problem solved

Functional benefit

Brands

• CONMED Foot and Ankle: Product division specializing in surgical solutions for foot and ankle procedures, including arthroplasty, biologics, fixation, implants, suture anchors, and instrumentation.

Products and services

• BioBrace

Quantifiable outcome

• 14 Nitinol options in NeoSpan® Compression Implant System
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Acumed: Specialist in orthopedic implants and instrumentation for the upper and lower extremities, with plating, fracture fixation, and small-bone systems directly overlapping In2Bones' portfolio.
• Paragon 28: Pure-play foot and ankle orthopedic company offering implants, fixation, biologics, and instrumentation across the same surgical specialties In2Bones targets, with comparable product breadth and customer base.
• Arthrex: Global orthopedic device company with deep extremity, sports medicine, and soft-tissue fixation portfolios (including suture anchors and small-joint arthroplasty) that overlap with In2Bones' sports-medicine foot/ankle offerings.
• Vilex: Foot and ankle focused orthopedic company producing plates, screws, and specialty implants for forefoot, midfoot, and hindfoot procedures — closely comparable to In2Bones' CoLink® plating family.

Broad incumbents

• Wright Medical (now Stryker): Historically a leading foot and ankle extremity franchise (now integrated into Stryker) offering total ankle, plating, and biologics that compete head-on with In2Bones' extremity portfolio.
• Stryker: Diversified orthopedic major with extremity, foot/ankle, sports medicine, and surgical power-tool lines that compete broadly with In2Bones across multiple product families.
• DePuy Synthes (Johnson & Johnson): Largest orthopedic franchise globally with extremity trauma plates, screws, and small-bone power systems overlapping In2Bones' fixation and instrumentation offerings.
• Zimmer Biomet: Broad-line orthopedic device manufacturer with extremity, foot/ankle, sports medicine, and biologics portfolios that overlap with several of In2Bones' product categories.
• Smith+Nephew: Global medical device company with sports medicine, extremity, and arthroscopy lines that overlap with In2Bones' suture anchor, soft-tissue, and small-bone power offerings.

Emerging players

• Conventus Orthopaedics: Extremity-focused orthopedic company with proprietary cage/plate technology for fractures of the proximal humerus, distal radius, and proximal tibia — a comparable smaller specialist in adjacent extremity indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/conmed-foot-ankle
• Xx.com/in2bones

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about In2Bones